Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I would have to conjecture that this a buying opportunity .... almost no one is aware of Marjac's case - a failure will not hurt stock price .... however success would be a significant impetus ... based on such I see a buying opportunity
Lizzy - I wonder it they will tweet about eating unicorns ? Im not certain if unicorns have omega 3's in them - but I personally would not eat one ...
Give em a break Lizzy - tweeting about unicorns, daisies and sheroes is difficult work ....
Ultimately as all the information comes forward I dont see how a thinking judge could come to any other conclusion - even Judge Du admonished HIKMA not to infringe on the REDUCE IT patents ... the law is clearly being twisted and JUdge Andrews understands that ...
I dont believe BP will buy until uncertainty of patent litigation is resolved.
Never counted on revenue from CHina making much of a difference but hopefully I am wrong ...
In my naive untutored legal mind if I were a judge this seems pretty straight forward ....
A data table was altered
Does the adjustment matter with respect to the decision that was made
I'm not a statistics expert
I hire statistics expert and ask them
Case Over ...
Not to stir up a hornets nest and I Am NOT TAKING SIDES ONE WAY OR THE OTHER - I wear my mask all day long .... but ... I believe the US has had one death from the Omicron variant - many more die of flu - we do not shut society down for the flu -
I guess this has been the issue for many people all along - the inconsistent application of science ....
wow Thanks Capt Beer I did not see that statement before -- JUdge Andrews gets it !! Finally - a judge who has common sense
Everyone is infringing yet nobody is responsible !! That's it in a nutshell - PBM's, Pharmacy chains, insurers , manufacturers all infringe yet none are responsible !
Seems to parallel society hundreds loot a store no one is held responsible yet the business owner loses thousands of dollars !!
DK hopefully, but I have 6 Vascepa rejections sitting in my inbox -- many of them suggesting the patient take lovaza -- I dont have time to fight AMRN's battles ...
Only problem is 95% of doctors would give them an otc omega 3 -
JZ has been lurking in the shadows all along I can't help but to think that hes still pulling some of the strings of the puppets ....
Looks like they fixed the place up from several years ago but I am confused ...there are no daisies
I have noted a lot more daisies lately so I think they have been rather busy ...
Yes JT and Kennedy are next ... but not willingly - law suit may go after them personally beyond insurance recovery
It would be great if we could get reddit involved in this fiasco of a quagmire run by buffoons ... or we could buy lottery tickets .... lol
This article says absolutely nothing ....
The post that indicated Sarissa sold out ...
they are really mixing it up today instead of daisies and unicorns it will be roses and fairies .... and of course sheroes ....
Lizzy or anyone else when does a 13-f have to be filed ? End of quarter coming soon and we can see if this is a lie or not ...
Jeld wen products are very inferior I am starting class action suit feel free to comment
Windows after 15 years supposedly aluminum clad premium product are totally rotted
Hilarious ... the only thing that would have made it better would be a unicorn running across the screen holding a daisy in his mouth and clutching at his chest ....lol
Gatorz - 100% premium is considered very good $6 -- no way anyone is anyone giving $24 for this dog -- KM might be making a deal in the background at $6 and a good spot for himself in the larger company .....
Several months ago I spoke with a gentleman who was at genius level graduated from our local IVY he established a company which utilizes AI to make decisions in microseconds on what other AI systems are predicting for the market - basically they are making day traders look like sloths ...and he was being very successful -
Design algorithms that will predict market movement in seconds - make it public then design a new system that analyzes the previous one .... brilliant ... not ethical
All the lemmings think they know whats going on and guys like this are playing them like a violin
They ARE doing something their marketing team is working on daisies the reps are making unicorns and they are sending these in moon shots to aliens meanwhile patients, doctors and insurance companies remain clueless -
Yesterday I did a consultation for an investment firm on ldl and cad
Numerous questions offering choices as answers statins pcsk9's zetia nebivolol sglt's and guess what ...the designers of the study were not even aware of vascepa !!! Vascepa not even mentioned .... hilarious
OH well I bought mostly at $3.xx and $4.25 soo will just see what happens but for the people here who bought at much higher I feel badly for you - I am hoping the law suit goes after the old execs who used the company as their personal piggy bank to raid whenever they wished ...
AMRN is being sued and they are talking about going after old execs ..not just the insurance money ...
NIce ... but this company just cant get any traction - at one point the wheels were spinning and not going anywhere - now the wheels arent even spinning ...lol
YEs BP might at this point offer $5 per share
WE could hope that AMRN is sitting back waiting=for the legal issues to clear one way or the other - planning a combo pill - addressing insurance companies etc - but I am afraid to say the reality is this company was clueless when they rolled vascepa out and unfortunately they remain clueless - therein lies the problem
here is on of the numerous rejections that I receive for the med :
Maybe they cant legally use the term 'enhancer'
Does anyone have access to rx numbers in germany ?
100% premium - that would be $6.60 for AMRN ...lol
when was that filed ?
They are probably working on daisies and unicorns as well as sheroes ...
Agree - the idea is to get physician to associate vascepa with a statin --- not a fish oil - so if its a statin enhancer they think of vascepa every time someone is on a statin ..... it is opening the docs mind to association --- this is what marketing should be doing - how do you get the doc to think about your med ---- docs have been using statins for 30 years, statins are the mainstay of treatment, statin thought is well embedded, statins have opened the door ...now simply ride on statins back through the door !!
Yes ...many times - they are trying to see if it might fit in with unicorns and daisies
This is the essence of the failed marketing
1.)it is not an Omega 3 its a STATIN ENHANCER !
2.)It is for treatment of CVD risk NOT triglycerides
3.)There are NO OTHER omega 3's that cna legally claim this
and the ff letter should be sent to every pharmacy, PBM and insurer
I am writing today to clarify the appropriate positioning of medications known as OMEGA -3. These medications are often called “fish oil” by people without adequate knowledge. It is important to realize that there are many types of Omega 3 oils but for our purposes we need to only discuss two, DHA and EPA. There are significant differences in how each of these substance react at the biochemical level within the human body. I will not delve into this, for brevity's sake, but suffice it to say that EPA substantially reduces inflammation.
Lovaza (and generic Lovaza) contains DHA and EPA. Lovaza (and its generic) is only approved to reduce triglycerides over 500mg/dl . Lovaza actually increases LDL by a whopping 49%. It is theorized that this is a result of the DHA component.
Vascepa is pure EPA (Isocapent ethyl). In a landmark study called REDUCE IT – Coronary events were reduced by a substantial 25% in individuals already on statins who were prescribed Vascepa . (The reduction would have probably been much more on individuals not taking statins ) Recent analysis of data also suggests CVA reduction by 30% . It is theorized that EPA is achieving this by reduction of inflammation. Vascepa is a STATIN ENHANCER !
Appropriate classification and positioning of Omega 3 medications.
Lovaza (L) and Generic Lovaza (gL)
These are a combinations of EPA and DHA. The only appropriate utilization is for triglycerides > 500 to prevent pancreatitis. You should note that you have this listed under CARDIOVASCULAR DRUGS – antilipemics ( as you also have listed fibrates / niacin etc.) Please note NONE of these drugs have any outcomes study showing any improvement in Cardiovascular outcomes! Niacin has studies showing it has NO benefit for cardiovascular health. The only possible use of these medications is the reduction of triglycerides > 500 for the prevention of pancreatitis. Lovaza may actually induce cardiovascular disease since it increases LDL by 49%. These medications should NOT be listed as cardiovascular medicines.
Vascepa (V) and Generic Vascepa (gV)
These medications contain only EPA – both of these medication can be utilized for Trigs >500mg/dl, however, the fact of the matter is Lovaza (DHA /EPA) works better for pure trig reduction.
The vast majority of prescriptions written for Vascepa are for the REDUCE IT indications (individuals with known CAD or those with Diabetes and two risk factors on statins with trigs > 150 ), meaning it is being utilized to prevent cardiovascular disease. You cannot substitute Lovaza or generic lovaza for these prescriptions - they have NO indication for this and you may actually be harming the patient by increasing their LDL by 49% - Lovaza and Vascepa are DIFFERENT medications and are NOT Interchangeable.
Furthermore if a prescription is written for Vascepa for REDUCE IT indications (95% of use) you cannot substitute generic Vascepa – this is direct patent infringement and law suits are now being filed against insurers for such ( Healthnet). Generic Vascepa is ONLY approved for trigs >500 it is NOT approved for reduction of cardiovascular risk and doing so will expose you to liability for direct patent infringement.
In summary:
Omega 3's that can be used for Trigs >500
Lovaza – Generic Lovaza - Vascepa - Generic Vascepa
Omega 3's that can bu utilized for cardiovascular risk Reduction
VASCEPA - THE STATIN ENHANCER
Based on the SCience of REDUCE IT AMRN should be a booming company in 2024 ...based on the ineptness of management to market the product AND to prevail in legal battles its a failure .....
The only problem PD is acquisition price is rarely over 100% of stock price....
Excellent summary ! Yes this is all true which means we are holding the pearl - the whole question is does the man holding it know how to use it or will he just hold it until he dies ...